# Roche invests $550M to expand Indianapolis diagnostics manufacturing hub

Roche announced plans to invest up to $550 million by 2030 to expand its Diagnostics site in Indianapolis, establishing it as a hub for manufacturing continuous glucose monitoring (CGM) systems. The expansion will create hundreds of jobs.

- Type: Expansion
- Announced: 2025-05-12
- Where: Indianapolis, Indiana, United States
- Value: $550.0M
- Starts operating: 2030
- Status: announced
- Products: continuous glucose monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Roche Diagnostics](https://endata.com/companies/29985.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/roche-announces-550-million-investment-to-expand-its-indianapolis-diagnostics-manufacturing-hub-302452305.html), 2025-05-12: "By expanding our manufacturing capabilities in Indianapolis, we ensure reliable access to innovative monitoring solutions for individuals living with diabetes in the U.S. and worldwide."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.